Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Dec;12(12):4715-26.
doi: 10.1002/j.1460-2075.1993.tb06160.x.

Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains

Affiliations

Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains

J F Cáceres et al. EMBO J. 1993 Dec.

Abstract

Human pre-mRNA splicing factor SF2/ASF has an activity required for general splicing in vitro and promotes utilization of proximal alternative 5' splice sites in a concentration-dependent manner by opposing hnRNP A1. We introduced selected mutations in the N-terminal RNA recognition motif (RRM) and the C-terminal Arg/Ser (RS) domain of SF2/ASF, and assayed the resulting recombinant proteins for constitutive and alternative splicing in vitro and for binding to pre-mRNA and mRNA. Mutants inactive in constitutive splicing can affect alternative splice site selection, demonstrating that these activities involve distinct molecular interactions. Specific protein-RNA contact mediated by Phe56 and Phe58 in the RNP-1 submotif of the SF2/ASF RRM are essential for constitutive splicing, although they are not required for RRM-mediated binding to pre-mRNA. The RS domain is also required for constitutive splicing activity and both Arg and Ser residues are important. Analysis of domain deletion mutants demonstrated strong synergy between the RRM and a central degenerate RRM repeat in binding to RNA. These two domains are sufficient for alternative splicing activity in the absence of an RS domain.

PubMed Disclaimer

References

    1. Biochemistry. 1983 May 24;22(11):2601-10 - PubMed
    1. Curr Opin Cell Biol. 1992 Jun;4(3):444-52 - PubMed
    1. Clin Exp Rheumatol. 1984 Apr-Jun;2(2):131-7 - PubMed
    1. Cell. 1985 Oct;42(3):725-36 - PubMed
    1. New Biol. 1992 May;4(5):421-9 - PubMed

Publication types